Supreme Court rules for Bayer in Roundup warning-label dispute

The U.S. Supreme Court ruled 7-2 for Bayer on Thursday in a Roundup warning-label dispute, a decision that could sharply narrow thousands of lawsuits tied to claims that the weedkiller should carry a cancer warning.

The court said federal pesticide law preempts state failure-to-warn claims when the Environmental Protection Agency has not required a cancer warning on the label. The ruling gives Bayer its biggest legal victory yet in years of litigation over glyphosate-based Roundup.

The case centered on John Durnell, who won a $1.25 million verdict in Missouri after arguing that Roundup caused his non-Hodgkin lymphoma. Bayer appealed, arguing that federal labeling rules should control and that state-law claims cannot force a warning the EPA has not required.

What the court decided

Justice Brett Kavanaugh wrote the majority opinion. Justice Ketanji Brown Jackson dissented.

The majority focused on the conflict between federal pesticide regulation and state tort claims. In practical terms, the ruling says companies cannot be held liable under state failure-to-warn theories for omitting a cancer warning when the federal regulator has not demanded one.

That makes the preemption question central: whether federal approval of a pesticide label leaves room for state juries to impose a different warning standard. The court’s answer, in this case, was no.

Why the ruling matters

The decision is expected to block or dismiss many pending Roundup failure-to-warn lawsuits. Lower courts are likely to apply the ruling to active cases as Bayer seeks to narrow or end the remaining warning-based claims.

Roundup litigation has been a major overhang for Bayer since it acquired Monsanto in 2018. The company has faced years of verdicts, appeals and settlement pressure over claims that the herbicide caused cancer.

The ruling may also matter beyond Roundup. It could affect similar failure-to-warn claims involving other pesticide makers if those cases turn on the same clash between federal label approval and state law.

Background to the case

Roundup is a glyphosate-based herbicide originally sold by Monsanto and now owned by Bayer. The legal fight has turned on whether pesticide makers had a duty under state law to add cancer warnings even though the EPA had not required them to do so.

Durnell's Missouri verdict became one of the cases Bayer pushed to the Supreme Court. The company argued that allowing state warning claims to stand would undermine the federal regulatory system for pesticide labeling.

Reaction and next steps

Bayer said the decision supports science, farmers and regulatory clarity, and should help contain the Roundup litigation. The company has long argued that the federal framework should prevent jury verdicts from imposing inconsistent labeling obligations.

Critics of that position say EPA approval does not settle whether a product is safe. That dispute is likely to continue, even if the ruling makes warning-based claims much harder to pursue.

The immediate question is how quickly lower courts clear out the docket and whether plaintiffs can keep any claims alive under different legal theories. Plaintiffs and public-health advocates may shift toward other approaches, while Bayer moves to use the ruling to press for dismissals or narrower settlements.